Evidence map›Paper›PMID 42740139›Full record

ArticleSensors (Basel, Switzerland)2026

XChondNet: Explainable Chondrogenic Tumor Diagnosis by Spatial-Context-Aware Synergistic Deep Feature Fusion.

Shuai Xiao, Yuefeng Xie, Guipeng Lan, Aidong Liu, Jiachen Yang

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shuai XiaoSchool of Electrical and Information Engineering, Tianjin University, Tianjin 300072, China.ORCID 0000-0003-4058-8120
Yuefeng XieSchool of Electrical and Information Engineering, Tianjin University, Tianjin 300072, China.
Guipeng LanSchool of Electrical and Information Engineering, Tianjin University, Tianjin 300072, China.ORCID 0000-0001-7321-7460
Aidong LiuDepartment of Pathology, Tianjin Hospital, No. 406 Jiefang Nan Street, Hexi District, Tianjin 300211, China.ORCID 0000-0002-9025-7111
Jiachen YangSchool of Electrical and Information Engineering, Tianjin University, Tianjin 300072, China.ORCID 0000-0003-2558-552X

Funding

National Natural Science Foundation of China 62271345National Natural Science Foundation of China 62306211
6 · The paper itself

Abstract

As a common benign bone tumor, the pathological diagnosis of chondrogenic tumors needs to accurately analyze the calcification pattern of the cartilage matrix, key spatial topology information, and other important indicators. However, chondrogenic tumors are a heterogeneous group of tumors and a rare disease: doctors lack sufficient reference data and experience in diagnosis. At the same time, complex spatial structural information also increases the difficulty of diagnosis, which leads to inconsistencies in the diagnosis's results of different doctors. In contrast, with the development of technology, artificial intelligence (AI), with its fast, accurate, and robust characteristics, can effectively improve the efficiency and accuracy of diagnosis. However, the application of AI in this field is still unrecognized, so it is urgent to develop a model that can help doctors in diagnosis to improve accuracy and efficiency. In this study, we propose XChondNet, an explainable spatial-context-aware synergistic deep feature fusion model for WSI-based chondrogenic tumor classification. The model proposes a fusion mechanism of pathological and positional features so that the model can effectively perceive spatial structural information and a parallel classifier mechanism based on potential coding, which can effectively solve the problem of class imbalance in chondrogenic tumor data. We evaluated the XChondNet model on our chondrogenic tumor dataset and the experimental results verified its effectiveness in the classification of the chondrogenic tumor subtype. In the test phase, XChondNet consistently achieved superior performance across different feature extractors. Compared with two strong MIL baselines, DTFD-MIL and RRT-MIL, XChondNet improved the average ACC from 85.16% to 86.58% (1.42 percentage points), with statistically significant differences confirmed by a paired

Indexed as

Bone NeoplasmsAlgorithmsArtificial IntelligenceHumanschondrogenic tumorsdigital pathology imagesfeature fusionparallel classifier mechanismtumor diagnosis

Identifiers

PMID42740139
PMCPMC13568048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.